 | • レポートコード：MRC23Q36390 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の無菌フィルフィニッシュCMO市場について調査・分析し、世界の無菌フィルフィニッシュCMO市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（バイアル、プレフィルドシリンジ、カートリッジ、その他）、用途別セグメント分析（ワクチン、バイオ医薬品、バイオシミラー、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Baxter BioPharma Solutions、Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CentreOne、Aenova、WuXi Biologics、Jubilant HollisterStier、Bushu Pharmaceuticals、LSNE Contract Manufacturing、Ajinomoto Bio-Pharma Services、CMIC CMO、GRAM (Grand River Aseptic Manufacturing)、TAIYO Pharma Tech Co.,Ltd.、HALIX、Cognate BioServices、Afton Scientific、Novasep、Emergent BioSolutions、Seikagaku、Jiangshu YAOHAI Bio-pharmaceutical、Akron Biotech、Symbiosis Pharmaceutical Services、Techdow、Vigene Biosciencesなどが含まれています。 世界の無菌フィルフィニッシュCMO市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、無菌フィルフィニッシュCMO市場規模を推定する際に考慮しました。本レポートは、無菌フィルフィニッシュCMOの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、無菌フィルフィニッシュCMOに関するビジネス上の意思決定に役立てることを目的としています。 ・無菌フィルフィニッシュCMO市場の概要 - 無菌フィルフィニッシュCMOのタイプ別セグメント - 世界の無菌フィルフィニッシュCMO市場規模：タイプ別分析（バイアル、プレフィルドシリンジ、カートリッジ、その他） - 無菌フィルフィニッシュCMOの用途別セグメント - 世界の無菌フィルフィニッシュCMO市場規模：用途別分析（ワクチン、バイオ医薬品、バイオシミラー、その他） - 世界の無菌フィルフィニッシュCMO市場規模予測（2018年-2029年） ・無菌フィルフィニッシュCMO市場の成長トレンド - 無菌フィルフィニッシュCMOの地域別市場規模（2018年-2029年） - 無菌フィルフィニッシュCMO市場ダイナミクス - 無菌フィルフィニッシュCMOの業界動向 - 無菌フィルフィニッシュCMO市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：バイアル、プレフィルドシリンジ、カートリッジ、その他 - 世界の無菌フィルフィニッシュCMOのタイプ別市場規模（2018年-2023年） - 世界の無菌フィルフィニッシュCMOのタイプ別市場規模（2024年-2029年） ・用途別セグメント：ワクチン、バイオ医薬品、バイオシミラー、その他 - 世界の無菌フィルフィニッシュCMOの用途別市場規模（2018年-2023年） - 世界の無菌フィルフィニッシュCMOの用途別市場規模（2024年-2029年） ・無菌フィルフィニッシュCMOの地域別市場規模 - 北米の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - アメリカの無菌フィルフィニッシュCMO市場規模（2018年-2029年） - ヨーロッパの無菌フィルフィニッシュCMO市場規模（2018年-2029年） - アジア太平洋の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - 中国の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - 日本の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - 韓国の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - インドの無菌フィルフィニッシュCMO市場規模（2018年-2029年） - オーストラリアの無菌フィルフィニッシュCMO市場規模（2018年-2029年） - 中南米の無菌フィルフィニッシュCMO市場規模（2018年-2029年） - 中東・アフリカの無菌フィルフィニッシュCMO市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Baxter BioPharma Solutions、Boehringer Ingelheim、Vetter Pharma、Fresenius Kabi、Pfizer CentreOne、Aenova、WuXi Biologics、Jubilant HollisterStier、Bushu Pharmaceuticals、LSNE Contract Manufacturing、Ajinomoto Bio-Pharma Services、CMIC CMO、GRAM (Grand River Aseptic Manufacturing)、TAIYO Pharma Tech Co.,Ltd.、HALIX、Cognate BioServices、Afton Scientific、Novasep、Emergent BioSolutions、Seikagaku、Jiangshu YAOHAI Bio-pharmaceutical、Akron Biotech、Symbiosis Pharmaceutical Services、Techdow、Vigene Biosciences ・アナリストの観点/結論 ・調査方法とデータソース |
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
Highlights
The global Sterile Fill-Finish CMO market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Sterile Fill-Finish CMO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Sterile Fill-Finish CMO is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Sterile Fill-Finish CMO in Vaccines is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Sterile Fill-Finish CMO include Baxter BioPharma Solutions, Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, Pfizer CentreOne, Aenova, WuXi Biologics, Jubilant HollisterStier and Bushu Pharmaceuticals, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sterile Fill-Finish CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Fill-Finish CMO.
The Sterile Fill-Finish CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sterile Fill-Finish CMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Fill-Finish CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics
Biosimilar
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Fill-Finish CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Fill-Finish CMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vials
1.2.3 Prefilled Syringes
1.2.4 Cartridges
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Fill-Finish CMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccines
1.3.3 Biologics
1.3.4 Biosimilar
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Fill-Finish CMO Market Perspective (2018-2029)
2.2 Sterile Fill-Finish CMO Growth Trends by Region
2.2.1 Global Sterile Fill-Finish CMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sterile Fill-Finish CMO Historic Market Size by Region (2018-2023)
2.2.3 Sterile Fill-Finish CMO Forecasted Market Size by Region (2024-2029)
2.3 Sterile Fill-Finish CMO Market Dynamics
2.3.1 Sterile Fill-Finish CMO Industry Trends
2.3.2 Sterile Fill-Finish CMO Market Drivers
2.3.3 Sterile Fill-Finish CMO Market Challenges
2.3.4 Sterile Fill-Finish CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Fill-Finish CMO Players by Revenue
3.1.1 Global Top Sterile Fill-Finish CMO Players by Revenue (2018-2023)
3.1.2 Global Sterile Fill-Finish CMO Revenue Market Share by Players (2018-2023)
3.2 Global Sterile Fill-Finish CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sterile Fill-Finish CMO Revenue
3.4 Global Sterile Fill-Finish CMO Market Concentration Ratio
3.4.1 Global Sterile Fill-Finish CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Fill-Finish CMO Revenue in 2022
3.5 Sterile Fill-Finish CMO Key Players Head office and Area Served
3.6 Key Players Sterile Fill-Finish CMO Product Solution and Service
3.7 Date of Enter into Sterile Fill-Finish CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Fill-Finish CMO Breakdown Data by Type
4.1 Global Sterile Fill-Finish CMO Historic Market Size by Type (2018-2023)
4.2 Global Sterile Fill-Finish CMO Forecasted Market Size by Type (2024-2029)
5 Sterile Fill-Finish CMO Breakdown Data by Application
5.1 Global Sterile Fill-Finish CMO Historic Market Size by Application (2018-2023)
5.2 Global Sterile Fill-Finish CMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sterile Fill-Finish CMO Market Size (2018-2029)
6.2 North America Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sterile Fill-Finish CMO Market Size by Country (2018-2023)
6.4 North America Sterile Fill-Finish CMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Fill-Finish CMO Market Size (2018-2029)
7.2 Europe Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sterile Fill-Finish CMO Market Size by Country (2018-2023)
7.4 Europe Sterile Fill-Finish CMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Fill-Finish CMO Market Size (2018-2029)
8.2 Asia-Pacific Sterile Fill-Finish CMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sterile Fill-Finish CMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Sterile Fill-Finish CMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Fill-Finish CMO Market Size (2018-2029)
9.2 Latin America Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sterile Fill-Finish CMO Market Size by Country (2018-2023)
9.4 Latin America Sterile Fill-Finish CMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Fill-Finish CMO Market Size (2018-2029)
10.2 Middle East & Africa Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sterile Fill-Finish CMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Sterile Fill-Finish CMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Detail
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Sterile Fill-Finish CMO Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Sterile Fill-Finish CMO Introduction
11.2.4 Boehringer Ingelheim Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Detail
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Sterile Fill-Finish CMO Introduction
11.3.4 Vetter Pharma Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Detail
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Sterile Fill-Finish CMO Introduction
11.4.4 Fresenius Kabi Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Detail
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Sterile Fill-Finish CMO Introduction
11.5.4 Pfizer CentreOne Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Detail
11.6.2 Aenova Business Overview
11.6.3 Aenova Sterile Fill-Finish CMO Introduction
11.6.4 Aenova Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Sterile Fill-Finish CMO Introduction
11.7.4 WuXi Biologics Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Detail
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Sterile Fill-Finish CMO Introduction
11.8.4 Jubilant HollisterStier Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Detail
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Sterile Fill-Finish CMO Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Detail
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Sterile Fill-Finish CMO Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Detail
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Sterile Fill-Finish CMO Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Detail
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Sterile Fill-Finish CMO Introduction
11.12.4 CMIC CMO Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Detail
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Sterile Fill-Finish CMO Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Detail
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Sterile Fill-Finish CMO Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Detail
11.15.2 HALIX Business Overview
11.15.3 HALIX Sterile Fill-Finish CMO Introduction
11.15.4 HALIX Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Detail
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Sterile Fill-Finish CMO Introduction
11.16.4 Cognate BioServices Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Detail
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Sterile Fill-Finish CMO Introduction
11.17.4 Afton Scientific Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Detail
11.18.2 Novasep Business Overview
11.18.3 Novasep Sterile Fill-Finish CMO Introduction
11.18.4 Novasep Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Detail
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Sterile Fill-Finish CMO Introduction
11.19.4 Emergent BioSolutions Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Detail
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Sterile Fill-Finish CMO Introduction
11.20.4 Seikagaku Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Detail
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Sterile Fill-Finish CMO Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Detail
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Sterile Fill-Finish CMO Introduction
11.22.4 Akron Biotech Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Detail
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Sterile Fill-Finish CMO Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Detail
11.24.2 Techdow Business Overview
11.24.3 Techdow Sterile Fill-Finish CMO Introduction
11.24.4 Techdow Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Detail
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Sterile Fill-Finish CMO Introduction
11.25.4 Vigene Biosciences Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.25.5 Vigene Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details